Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target

Area of Science:

• Virology
• Molecular Biology
• Emerging Infectious Diseases

Background:

• Global changes like climate change and globalization accelerate the emergence of novel pathogenic viruses.
• The coronavirus family, including SARS-CoV-2, poses significant threats due to rapid viral emergence.
• Understanding viral replication mechanisms is crucial for identifying therapeutic vulnerabilities.

Purpose of the Study:

• To review the virological significance of programmed -1 ribosomal frameshift (-1 PRF) in coronaviruses.
• To elucidate the molecular mechanisms underlying -1 PRF.
• To explore therapeutic strategies targeting -1 PRF in viral infections, with a focus on SARS-CoV-2.

Main Methods:

• Literature review of nearly 50 years of research on -1 PRF.
• Analysis of molecular mechanisms driving -1 PRF in viral replication.
• Discussion of therapeutic approaches to manipulate -1 PRF.

Main Results:

• Programmed -1 PRF is a critical mechanism for coronavirus replicase protein synthesis.
• Decades of research have illuminated the intricacies of -1 PRF.
• -1 PRF presents a druggable target for antiviral therapies.

Conclusions:

• Targeting the programmed -1 PRF mechanism offers a promising strategy for developing novel antiviral therapeutics.
• Further research into -1 PRF can yield effective treatments against emerging viral threats like SARS-CoV-2.
• The study highlights the importance of fundamental research in understanding and combating viral diseases.